TTT-3002 Is a Novel FLT3 Tyrosine Kinase Inhibitor That Has the Potential to Overcome Some of the Limitations of Current FLT3 Inhibitors in Treatment of Acute Myeloid Leukemia

Autor: Wall, Hayley S, Nguyen, Bao *, Li, Li *, Greenblatt, Sarah M *, Brown, Patrick, Levis, Mark J., Small, Donald
Zdroj: In Blood 16 November 2012 120(21):866-866
Databáze: ScienceDirect